Immunoassay Market Share ,Industry Size And Growth Analysis For Projected Period From 2019 To 2025
Increase in incidence of chronic and infectious diseases is expected to accelerate the demand.
(firmenpresse) - The Report Immunoassay Market Size, Share & Trends Analysis Report By Product (Reagents & Kits, Software & Services), By Technology (RIA, EIA, Rapid Test), By Application, By End Use, And Segment Forecasts, 2019 – 2025
The global immunoassay market size was estimated at USD 18.02 billion in 2018 and is expected to exhibit a CAGR of 5.0% during the forecast period. Increase in incidence of chronic and infectious diseases is expected to accelerate the demand. For instance, according to the World Health Organization (WHO), in 2017, about 65 million individuals in U.S. were suffering from Chronic Obstructive Pulmonary Disease (COPD). This factor is anticipated to bode well for regional demand in the forthcoming years.
Extensive usage of immunoassay techniques for detection of infectious and chronic diseases is the prime factor driving the growth. In addition, launch of novel products coupled with rapid technological advancements are anticipated to drive the market. For instance, Quidel Corporation received CE mark approval in 2018 for its product Sofia, which is a Quantitative Vitamin D Assay used with Sofia instrument.
Moreover, collaborations and partnerships among medical device giants are expected to provide new growth platforms for immunoassay techniques, such as radioimmunoassay, rapid tests, and enzyme immunoassays among others. For instance, Roche Diagnostics and GE Healthcare entered into a partnership to develop and market digital clinical decision systems in January 2018. This partnership aided in improving cancer and critical care.
Furthermore, automation has benefits such as efficiency and optimal usage of labor and space in laboratories. Thus, the immunoassay market is witnessing lucrative growth as some players are introducing automated laboratory systems, point-of-testing compact, and portable assay tests. For instance, launch of innovative products such as compact and portable ichroma II by Boditech Med, Inc., which is an FDA-approved fluorescence scanning instrument used for influenza screening.
North America held a significant market share in 2018, attributed to high R&D investments by pharmaceutical and medical device manufactures and favorable government insurance policies. For instance, in May 2018, a bill was approved by the U.S. congress, as per which an individual can try unproven medical aids, which includes drugs, medications, and devices, in case of severe illness.
Key Takeways Of The Report :
Reagents and kits accounted for a significant market share of about 72.0% in 2018, owing to extensive application of the products
Closed-ended systems is expected witness a profitable CAGR over the forecast period due to associated advantages, such as sterility, and cheaper rates as compared to open-ended systems
Asia Pacific is anticipated to witness significant CAGR over the forecast period due to rising healthcare spending and healthcare investments by many companies
Key players operating in the immunoassay market are Quidel Corporation; Ortho Clinical Diagnostics; Roche Diagnostics; and Thermo Fisher Scientific, Inc. among others
The industry participants engage in extensive research activities to develop novel immunoassays for diagnosis of infectious and chronic diseases.
Grand View Research has segmented the global immunoassay market report on the basis of product, technology, application, end use, and region:
Technology Outlook (Revenue, USD Million, 2014 - 2025)
Radioimmunoassay (RIA)
Enzyme Immunoassay (EIA)
Chemiluminescence Immunoassays (CLIA)
Fluorescence Immunoassays (FIA)
Rapid test
Others
Product Outlook (Revenue, USD Million, 2014 - 2025)
Reagents & kits
Analyzers/instruments
Open ended systems
Closed ended systems
Software & services
Application Outlook (Revenue, USD Million, 2014 - 2025)
Therapeutic drug monitoring
Oncology
Cardiology
Endocrinology
Infectious disease testing
Autoimmune diseases
Others
End Use Outlook (Revenue, USD Million, 2014 - 2025)
Hospitals
Blood banks
Clinical laboratories
Pharmaceutical and biotech companies
Academic research centers
Others
Regional Outlook (Revenue, USD Million, 2014 - 2025)
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com
Themen in dieser Pressemitteilung:
immunoassay-market
immunoassay
immunoassay-applications
classification-of-immunoassay
application-of-immunoassay
different-types-of-immunoassays
disadvantages-of-immunoassay
Unternehmensinformation / Kurzprofil:
Datum: 15.10.2019 - 11:18 Uhr
Sprache: Deutsch
News-ID 600508
Anzahl Zeichen: 5274
contact information:
Contact person: Sonali Kulkarni
Town:
San Francisco
Phone: 14153490058
Kategorie:
Medical Devices
Typ of Press Release: please
type of sending: don't
Diese Pressemitteilung wurde bisher 176 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Immunoassay Market Share ,Industry Size And Growth Analysis For Projected Period From 2019 To 2025 "
steht unter der journalistisch-redaktionellen Verantwortung von
Grand View Research Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
